ATE349420T1 - Azulenylnitrone als radikal fanger (spin trapping agents), verfahren zu ihrer herstellung und ihre anwendung - Google Patents

Azulenylnitrone als radikal fanger (spin trapping agents), verfahren zu ihrer herstellung und ihre anwendung

Info

Publication number
ATE349420T1
ATE349420T1 AT96940538T AT96940538T ATE349420T1 AT E349420 T1 ATE349420 T1 AT E349420T1 AT 96940538 T AT96940538 T AT 96940538T AT 96940538 T AT96940538 T AT 96940538T AT E349420 T1 ATE349420 T1 AT E349420T1
Authority
AT
Austria
Prior art keywords
agents
radical species
present
azulenyl nitrones
production
Prior art date
Application number
AT96940538T
Other languages
English (en)
Inventor
David A Becker
Original Assignee
Florida Internat University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Florida Internat University filed Critical Florida Internat University
Application granted granted Critical
Publication of ATE349420T1 publication Critical patent/ATE349420T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
    • C07C291/02—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
    • C07C291/02—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
    • C07C291/04—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds containing amino-oxide bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
    • C07C2602/30—Azulenes; Hydrogenated azulenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96940538T 1995-11-17 1996-11-15 Azulenylnitrone als radikal fanger (spin trapping agents), verfahren zu ihrer herstellung und ihre anwendung ATE349420T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US694995P 1995-11-17 1995-11-17
US2463196P 1996-08-27 1996-08-27

Publications (1)

Publication Number Publication Date
ATE349420T1 true ATE349420T1 (de) 2007-01-15

Family

ID=26676282

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96940538T ATE349420T1 (de) 1995-11-17 1996-11-15 Azulenylnitrone als radikal fanger (spin trapping agents), verfahren zu ihrer herstellung und ihre anwendung

Country Status (8)

Country Link
US (3) US6083988A (de)
EP (1) EP0888290B1 (de)
JP (1) JP3887020B2 (de)
AT (1) ATE349420T1 (de)
AU (1) AU7739796A (de)
CA (1) CA2235765C (de)
DE (1) DE69636795D1 (de)
WO (1) WO1997019054A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376540B1 (en) * 1996-07-19 2002-04-23 Centaur Pharmaceuticals, Inc. Furan nitrone compounds
TW429241B (en) * 1996-09-26 2001-04-11 Sumitomo Pharma Nitrone derivatives
US6046232A (en) * 1997-10-17 2000-04-04 Centaur Pharmaceuticals, Inc. α-aryl-N-alkylnitrones and pharmaceutical compositions containing the same
JP2002509143A (ja) * 1998-01-16 2002-03-26 センター ファーマシューティカルズ， インコーポレイテッド チオエーテルフランニトロン化合物
AU2226999A (en) * 1998-01-16 1999-08-02 Renovis, Inc. Thiophene nitrone compounds
FR2780404B1 (fr) * 1998-06-26 2001-04-13 Adir Nouveaux derives de nitrone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6566320B1 (en) 1999-10-19 2003-05-20 The Procter & Gamble Company Bleaching composition containing chromotropic compound
EP1094106A1 (de) * 1999-10-19 2001-04-25 The Procter & Gamble Company Reinigungsmittelzusammensetzung
US6569826B1 (en) 1999-10-19 2003-05-27 The Procter & Gamble Company Radical scavenger
GB0024938D0 (en) * 2000-10-11 2000-11-29 Queen Mary & Westfield College Method of diagnosis
AU2002253857A1 (en) 2001-01-08 2002-09-04 Centaur Pharmaceuticals, Inc. Use of aryl nitrone compounds in methods for treating neuropathic pain
US6746808B2 (en) 2001-08-29 2004-06-08 Fuji Xerox Co., Ltd. Image forming color toner, color image forming method and color image forming apparatus
US6762322B1 (en) * 2002-12-20 2004-07-13 Goodyear Tire & Rubber Company Preparation of nitrone derivatives
US20050182060A1 (en) * 2004-02-13 2005-08-18 Kelly Michael G. 2-Substituted and 4-substituted aryl nitrone compounds
WO2006036768A2 (en) 2004-09-22 2006-04-06 The Florida International University Board Of Trustees Azulenyl nitrone spin trapping agents, methods of making and using same
GB0518890D0 (en) * 2005-09-15 2005-10-26 Ucl Biomedica Plc Method of determining damage to skin
WO2008002614A2 (en) * 2006-06-28 2008-01-03 The Florida International University Board Of Trustees Pseudoazulenyl nitrones
GB0623758D0 (en) * 2006-11-25 2007-01-10 Univ Salford The Free radical trapping
WO2009102808A2 (en) 2008-02-12 2009-08-20 Tosk, Incorporated Doxorubicin adjuvants to reduce toxicity and methods for using the same
US8313456B2 (en) * 2009-06-30 2012-11-20 Palo Alto Research Center Incorporated Drug-transfer device, drug-delivery system incorporating the same, methods of fabricating the same, and methods of enabling administration of a drug
US9034926B2 (en) 2010-12-30 2015-05-19 Nicholas V. Perricone Topical nitrone spin trap compositions for psoriasis
WO2013067084A1 (en) * 2011-11-01 2013-05-10 The Florida International University Board Of Trustees Silylated azulenyl nitrone spin traps as chromotropic superoxide detectors
GB201217228D0 (en) * 2012-09-26 2012-11-07 Pepric Nv Methods and systems for determining a particle distribution
US9971038B2 (en) 2013-03-15 2018-05-15 The Florida International University Board Of Trustees Chromotropic detection of ionizing radiation
US10323147B1 (en) 2016-05-26 2019-06-18 Marathon Petroleum Company Lp Asphalt composition containing ester bottoms
US11814506B2 (en) 2019-07-02 2023-11-14 Marathon Petroleum Company Lp Modified asphalts with enhanced rheological properties and associated methods
US12304377B2 (en) 2020-05-21 2025-05-20 Marathon Petroleum Company Lp Systems and methods for venting tanks to enhance transporting asphalt

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US35112A (en) * 1862-04-29 Improvement in head-rests for car-seats
US35213A (en) * 1862-05-13 Improved hydrant
US3509215A (en) * 1967-06-15 1970-04-28 Givaudan Corp Acyl indan compounds
US4141995A (en) * 1975-04-17 1979-02-27 Lilly Industries Limited Ketone derivatives
JPS5916867A (ja) * 1982-07-21 1984-01-28 Nippon Chemiphar Co Ltd 新規アズレン誘導体およびその製造法
US4990665A (en) * 1982-11-01 1991-02-05 Microsi, Inc. Diarylnitrones
JPS6197238A (ja) * 1984-10-17 1986-05-15 Ajinomoto Co Inc 新規アズレン誘導体およびその用途
JPS63239248A (ja) * 1986-11-07 1988-10-05 Ajinomoto Co Inc 抗脂血剤
CA2069961C (en) * 1989-10-17 2000-05-02 John M. Carney Method and compositions for inhibition of disorders associated with oxidative damage
US5025032A (en) 1989-10-17 1991-06-18 Oklahoma Medical Research Foundation Phenyl butyl nitrone compositions and methods for treatment of oxidative tissue damage
USRE35213E (en) 1989-10-17 1996-04-16 Oklahoma Medical Research Foundation Phenylbutyl nitrone compositions and methods for prevention of gastric ulceration
US5235076A (en) * 1991-05-28 1993-08-10 University Of Hawaii Azulenic retinoid compounds, compositions and methods
US5292746A (en) * 1991-09-12 1994-03-08 Merrell Dow Pharmaceuticals Inc. Cyclic nitrones, pharmaceutical compositions thereof and their use in treating shock
US5488145A (en) * 1993-12-23 1996-01-30 Oklahoma Medical Research Foundation 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps

Also Published As

Publication number Publication date
US6291702B1 (en) 2001-09-18
JP3887020B2 (ja) 2007-02-28
CA2235765C (en) 2006-04-04
EP0888290A4 (de) 2004-08-18
WO1997019054A1 (en) 1997-05-29
US6197825B1 (en) 2001-03-06
US6083988A (en) 2000-07-04
JP2000501081A (ja) 2000-02-02
CA2235765A1 (en) 1997-05-29
AU7739796A (en) 1997-06-11
EP0888290B1 (de) 2006-12-27
EP0888290A1 (de) 1999-01-07
DE69636795D1 (de) 2007-02-08

Similar Documents

Publication Publication Date Title
ATE349420T1 (de) Azulenylnitrone als radikal fanger (spin trapping agents), verfahren zu ihrer herstellung und ihre anwendung
DE69832209D1 (de) Verfahren zur Herstellung von 3,3-Dimethylbutyraldehyd durch Oxidation von 3,3-Dimethylbutanol
DE69615453D1 (de) Verfahren zur Herstellung von mikrokapselhaltigen Zusammensetzungen
DE69532137D1 (de) Verbessertes verfahren zur stabilisierung biologischer substanzen während der trocknung und anschliessender lagerung sowie die entsprechenden zusammensetzungen
DE59504613D1 (de) Verfahren zur Herstellung von Aldehyden
DE69534190D1 (de) Verfahren zur Herstellung von 1,2-Benzisothiazol-3-onen
DE69823662D1 (de) 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen
DE59407551D1 (de) Verfahren zur Herstellung von Triphenylphosphin
DE59503847D1 (de) Verfahren zur Herstellung von 3,5-Dimethylpyrazol-blockierten Polyisocyanaten
DE59602230D1 (de) Verfahren zur Herstellung von 2,2-Difluorbenzo[1.3]dioxolcarbaldehyden
DE59601745D1 (de) Verfahren zur Herstellung von 3-Aminomethyl-3,5,5-trimethylcyclohexylamin
DE69511788D1 (de) Verfahren zur Herstellung von 1,1,1,3,3-Pentafluorpropan
DE3873524D1 (de) Iodierte polymere, verfahren zu ihrer herstellung und ihre verwendung als kontrastmittel.
DE59502572D1 (de) Verfahren zur Herstellung von 2-Halogenpyridinaldehyden
DE69820580D1 (de) Verfahren zur Abtrennung von Metallen durch micellare Ultrafiltration, geeignet zur Behandlung von radioaktiven Abfallstoffen
DE59510180D1 (de) Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethyl-piperidin
DE69702870D1 (de) Verfahren zur Herstellung von Perlpolymerisaten aus Acrylaten
DE69519203D1 (de) Verfahren zur Herstellung von Extrakten enthaltende polyphenalische oligomere Verbindungen von Catechin-Typ, aus pflanzenartigen Quellen, und diese erhaltene Extrakte
DE69514122D1 (de) Lösungsmittelfreies verfahren zur herstellung von 2,6 difluorbenzonitril
DE59500393D1 (de) Verfahren zur Herstellung von Cyclopropylalkylketonen und 4,5-Dihydroalkylfuranen
DE59607664D1 (de) Verfahren zur Herstellung von 2,4,4,7-Tetramethyl-oct-6-en-3-on und dessen Verwendung als Riechstoff
DE69701936D1 (de) Verfahren zur Herstellung von Amiden aus Oximen
DE69503100D1 (de) Verfahren zur Herstellung von 3,4-Carandiol
DE69926223D1 (de) Verfahren zur herstellung von zwischenprodukten
DE69321284D1 (de) Verfahren zur Herstellung von durch Pfropfung modifizierten Copolymerisaten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties